Fluconazole and Ofirmev drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fluconazole (fluconazole) and Ofirmev (acetaminophen). Common drug interactions include burning sensation among females and alanine aminotransferase increased among males.
The phase IV clinical study analyzes what interactions people have when they take Fluconazole and Ofirmev. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Fluconazole?
Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.
What is Ofirmev?
Ofirmev has active ingredients of acetaminophen. eHealthMe is studying from 817 Ofirmev users. Check the latest studies of Ofirmev.
13 people who take Fluconazole and Ofirmev together, and have interactions are studied.

What are the common drug interactions of Fluconazole and Ofirmev, by gender? *:
female:
- Burning sensation
- Erythema (redness of the skin)
- Pruritus (severe itching of the skin)
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Skin lesion
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
- Anxiety
- Aspartate aminotransferase increased
male:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Staphylococcal bacteraemia (a bacterial infection of blood)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
- Body temperature increased
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Gamma-glutamyltransferase increased
- Hypertransaminasaemia
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
What are the common drug interactions of Fluconazole and Ofirmev, by age (0-1 to 60+)? *:
0-1:
- Gamma-glutamyltransferase increased
- Hypertransaminasaemia
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Burning sensation
- Erythema (redness of the skin)
- Pruritus (severe itching of the skin)
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Skin lesion
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
50-59:
- Aspartate aminotransferase increased
- Blood bilirubin increased
- Alanine aminotransferase increased
- Chronic kidney disease
- Dizziness
- Fatigue (feeling of tiredness)
- Hyperhidrosis (abnormally increased sweating)
- Renal failure (kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
60+:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Pain
- Osteonecrosis (death of bone)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
- Anxiety
- Bone density decreased
- Bone loss
What are the existing conditions these people have? *
- Pain: 4 people, 30.77%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
- Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 15.38%
- High Blood Pressure: 2 people, 15.38%
- Cancer Pain: 2 people, 15.38%
- Constipation: 2 people, 15.38%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 15.38%
- Dehydration (dryness resulting from the removal of water): 2 people, 15.38%
- Drug Eruption (adverse drug reaction of the skin): 2 people, 15.38%
- Essential Hypertension (primary hypertension): 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Fluconazole and Ofirmev?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Fluconazole (70,481 reports)
- Ofirmev (817 reports)
Browse all drug interactions of Fluconazole and Ofirmev:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fluconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ofirmev:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fluconazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ofirmev and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on fluconazole and acetaminophen (the active ingredients of Fluconazole and Ofirmev, respectively), and Fluconazole and Ofirmev (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diflucan and Road Traffic Accident for Women aged 40-49 - 3 seconds ago
- Ketek and Vision Blurred for Men aged 60+ - 4 seconds ago
- Drug interactions of Rebetol and Naprosyn - 5 seconds ago
- Could Klor-Con cause Acetabulum Fracture? - 8 seconds ago
- Could Ativan cause Localised Infection? - 9 seconds ago
- Could Lisinopril cause Pleural Effusion? - 23 seconds ago
- Could Mupirocin cause Tenderness? - 28 seconds ago
- Could Intron A cause Urination - Painful? - 29 seconds ago
- Pseudotumor Cerebri and drugs of ingredients of cephalexin - 30 seconds ago
- Profen and Duodenal Ulcer Perforation for Women aged 60+ - 33 seconds ago